Strategic Partnerships Elevate The Green Organic Dutchman’s Premium Cannabis To Heady Future

Closing of $112 million in private placement financing fully funds expansion plans
Time-to-market accelerated as Aurora Cannabis inks strategic investment/partnership with TGOD
Highly anticipated IPO scheduled for March 2018
Organic, medical-grade cannabis grown at low cost increases profit margins

The Green Organic Dutchman Holdings Ltd. (“TGOD”) continues to make headlines as it forms strategic partnerships and banks investment funds to fuel the company’s expansion plans to become the largest organic cannabis company in the world. The company’s recent announcement of its closing of $112 million in private placement financing included a cornerstone investment of $55 million by marijuana industry powerhouse Aurora Cannabis Inc. (OTCQX: ACBFF) (TSX: ACB) (http://cnw.fm/5lHaB). To date, TGOD has raised $160 million with over 4,000 shareholders.

TGOD is setting the industry standard on several fronts, including environmental stewardship, natural resource sustainability and development of a consortium of world-class architectural, construction and utility management teams dedicated to responsible practices. As a Canadian licensed cannabis producer, TGOD prides itself on growing completely organic, pesticide-free, grown-in-live-soil cannabis. In an interview with Equities.com (http://cnw.fm/uL0cG), Danny Brody, TGOD’s vice president of investor relations, said that he believes the company’s commitment to growing medical grade cannabis sets it apart.

“From day one we believed that organic product is key,” Brody stated. “That is one of our key differentiators that we will be continuing as we build out our operation.”

With this new infusion from investors, TGOD is able to fully fund a 970,000 square foot expansion of its organic cannabis production facilities located in Ontario and Quebec, two of Canada’s most populated provinces. The facilities, capable of producing 116,000 kg of cannabis annually, are slated to come online in Q4 2018 and Q2 2019, respectively. While medical marijuana has been legal in Canada since 2001 and is projected to grow to $2.1 billion by 2020, the recreational marijuana market is expected to reach $22 billion by 2024, according to a Deloitte report (http://cnw.fm/vdFR1).

The “Canadian Advantage” is real and the opportunities are unparalleled, both in Canada and internationally, as TGOD management noted in its latest corporate presentation to shareholders. As the first G7 nation poised to legalize recreational marijuana use, Canada is having a profound impact on legalization efforts around the world. In contrast, there are 29 states in the U.S. that currently allow some form of marijuana use, although there are measures on several ballots that could add legal cannabis to the lawbooks in additional states in the near future (http://cnw.fm/Phxu6). John Kagia, a cannabis industry analyst for New Frontier Data, called the recent move toward Canadian legalization a “wake up call to all investors who were sitting on the sidelines, that this is really going to happen.”

Although full implementation of legal cannabis for adults in Canada is expected to be in place by July 2018, there is some waffling on the timing, as legislation allowing for recreational cannabis must still pass Parliament (http://cnw.fm/Sw33v). Health Minister Ginette Petitpas Taylor said lower levels of government have informed her that more time – as much as eight to 12 weeks – may be required following adoption of the law (http://cnw.fm/1Do8B).

Timing is important, as TGOD is proving with its recent investment news and early spring 2018 plans to transition from a privately-held company to a publicly-traded one. TGOD believes that its unique approach to producing high quality, pharma-grade cannabis, coupled with its solid commitment to core values, offers numerous opportunities for additional joint ventures, licensing and distribution partnerships for a sustainable and successful future.

For more information, visit the company’s website at www.TGOD.ca

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Skinvisible, Inc. (SKVI) Products Can Offer Protection against Highly Contagious Viruses like H3N2

2018 flu season could cost U.S. businesses $15 billion in lost productivity
Winter Olympics hit with norovirus, sickening 128 Olympic workers
Centers for Disease Control and Prevention urging public to wash hands, use hand sanitizer in battle against infection
DermSafe® antimicrobial hand sanitizer is 99.9 percent effective against a list of deadly bacteria and viruses

It’s a simple phrase: “Wash your hands and use a hand sanitizer,” but doing it correctly and with the right product can make the difference when it comes to protection against a nasty bacteria or virus. Using an antiseptic hand sanitizer lotion such as DermSafe®, which incorporates Skinvisible’s (OTCQB: SKVI) proprietary Invisicare® drug delivery technology, is another vital tool offering a barrier against potentially serious illnesses. Skinvisible Pharmaceuticals, Inc., developer of over 40 topical prescription, over-the-counter and cosmeceutical products using its patented Invisicare® polymer delivery systems, donated over 1,000 bottles of DermSafe® to the Canadian Olympic team for the 2016 Summer Games in Rio (http://cnw.fm/kP2Zb), the company has now sent the same supply for the Olympic team in South Korea for the 2018 Winter Games. It’s a timely donation and one that could make a significant difference to the welfare of the team.

In fact, every athlete at the 2018 Winter Olympic Games in Pyeongchang, South Korea, is taking extra precautions to stay healthy, especially after an outbreak of the highly contagious norovirus sickened more than 120 security staff and others, prompting organizers to deploy 900 military personnel to assist at the games (http://cnw.fm/xQ8m0). Even more alarming is the continuing number of deaths resulting from an aggressive influenza strain – H3N2 – affecting children and adults living in the continental United States (http://cnw.fm/z3RTl). The common thread running throughout all of these stories is an admonition from health care professionals urging the public to religiously “wash your hands” and use hand sanitizers. Germs can live on any surface, so washing hands and wearing an antimicrobial hand lotion like DermSafe® is one of the best ways to stop germs from hitching a ride (http://cnw.fm/27iFH).

One application of DermSafe provides a four-hour protective barrier that binds to the skin and actively combats the spread of germs between people and hard surfaces. The active ingredient is four percent chlorhexidine gluconate (CHG), the same active ingredient found in soaps used in hospital operating rooms. DermSafe offers long-term protection and destroys both gram-negative and gram-positive bacteria and viruses (http://cnw.fm/8jRb6). It has been tested and proven effective against a host of infectious germs, including Methicillin-resistant Staphylococcus aureus (MRSA), Escherichia coli (E. coli) and salmonella. Sales of DermSafe have already taken off in China, and the product will be marketed throughout the country.

This year’s flu outbreak could conceivably cost U.S. businesses anywhere from $15 billion to $21 billion in lost productivity, Andrew Challenger, vice president of global employment consulting firm Challenger, Gray & Christmas, Inc., said in a 2017-2018 Flu Season report (http://cnw.fm/u9cAg). The agency raised itd earlier estimates by 64 percent, stating the 2018 flu virus could cause more than 18 million U.S. employees to miss at least four 8-hour shifts.

“Sick workers may think they are doing the right thing by ‘toughing it out’ and coming into work when they feel ill,” Challenger said in a news article (http://cnw.fm/S1CJs). However, “they are only likely to spread their illness, potentially further interrupting optimum business operations.”

Prevention and protection is the key when it comes to avoiding infectious germs. Although this season’s flu strain is particularly vicious, experts continue to remind the public that washing hands often and applying a long-term, antimicrobial hand sanitizer such as Skinvisible’s DermSafe® offers scientifically-proven protection against bacteria and viruses.

For more information, visit the company’s website at www.Skinvisible.com

More from CannabisNewsWire

About CannabisNewsWire

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

AV1 Group, Inc. (AVOP) Announces Engagement of Strategic Corporate Advisor to Assist in Propelling LED Division

Jon Fortune joins AV1 as strategic corporate advisor
LED lighting is cost- and energy-efficient for companies, homes and grow houses
X-Fire Smart Systems™ is an innovative solution for smart cities and homes

AV1 Group, Inc. (OTC: AVOP) recently announced the addition of Jon Fortune to its team. In a news release, AV1 Group CEO Bryen Beglinger stated, “We welcome Jon to our team. He has a wealth of experience and with his expertise in renewable energy, he will be a significant asset. He has a number of contacts in the industry that he is already working with on co-development opportunities, solutions and building customer relationships for our LED division and Smart City projects. Jon will also be working with our wholly-owned subsidiary, X-Fire, Inc., to incorporate block chain technology to the current product offering.”

AV1 Group explores every opportunity to help each sector exceed revenue goals. Each division is prepared to be a strong competitor in its given market. Engaging strong contenders, like Fortune, is a strategic move toward the success of AVOP, as multiple subsidiaries are created under one umbrella.

The LED Division provides cost- and energy-efficient lighting solutions for companies, homes and grow houses. The long-lasting LED lighting is attractive to lighting designers and property managers and is sold under the subsidiary Intelligent Lighting Corp. Growth Spectrum™ is a product line marketed to the cannabis industry. A strategic partnership with the LED manufacturer allows the company entry into a fast-growing market with minimal overhead. CannaLighting™ is actively building strategic relationships in the LED sector to potentially provide solutions to a rapidly increasing number of grow houses and cultivation centers. LED lighting solutions are an important factor for these indoor agricultural environments.

X-Fire Smart Systems™ is part of AVOP’s innovative solutions for city smart grids, home and business lighting and ecommerce. Through this subsidiary, the company offers a range of smart technology. The Apollo LED Series is an intelligent lighting solution with the ability to provide street-wide wireless access. It is an all-in-one housing that incorporates a wireless MESH radio for secure remote access and monitoring of infrastructure. It allows for programmable diming schedules and motion or light sensors. Smart parking meters allow for the use of credit cards instead of quarters. Charging stations integrate to allow authorization of credit cards and report usage to power providers. Digital utility meters provide time and cost savings and better customer service, and the Apollo Picocell extends cellular coverage to places where there is no signal. Picocells provide coverage, capacity and cost savings in areas that can be difficult to reach.

Fortune promises to be a significant asset as AVOP continues to seek out existing hardware, software designers and manufacturers in the LED and smart city industries.

For more information, visit the company’s website at www.AV1Group.com

More from CannabisNewsWire

About CannabisNewsWire

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

ChineseInvestors.com, Inc. (CIIX) Reaching Chinese-Speaking Audience through Video Broadcasts and New Mobile App

CIIX diversifies methods of reaching its global Chinese-speaking audience, with projects ranging from a daily video broadcast from the NYSE on cryptocurrencies to the development of a new social media mobile app for the cannabis industry
Company’s new mobile app expected to be the first Chinese-language app offering reviews and discussion of cannabis products
‘Bitcoin MultiMillionaire’ is the company’s daily video broadcast from the NYSE prepared for its unique and expansive audience

ChineseInvestors.com, Inc. (OTCQB: CIIX) is reaching out to the global Chinese-speaking community through both daily video broadcasts on cryptocurrencies and, soon, a new mobile app focused on reviews and discussion of cannabis products. CIIX is involved in both product areas. The company is a diverse educational and consulting firm targeting the Chinese-speaking community in both China and the U.S.

In cryptocurrencies such as bitcoin, the company is active in educational activities, produces a daily video broadcast from the NYSE titled ‘Bitcoin MultiMillionaire’ and hosts a Bitcoin ATM in the lobby of its San Gabriel, California, headquarters.

In cannabis, CIIX has ChineseHempOil.com, Inc., a wholly-owned subsidiary. That company markets, both online and through traditional retail, a line of hemp-based health products. The line consists of premium private label oil made from non-industrial hemp, manufactured using a CO2 extraction process.

The company’s new cannabis mobile app, focused on marijuana reaching social media, was noted in the January editions of both the Tiny Gems Newsletter (http://cnw.fm/hDX1G) and the Serious Traders Newsletter (http://cnw.fm/4qtlF).

While the company reaches out to its audience in new ways, its subsidiary, CBD Biotechnology Co., Ltd., is also expanding its line of luxury skincare products (http://cnw.fm/Eauh2). Its products have been approved for sale in China by the China Food and Drug Administration (CFDA). CIIX has scheduled the launch of four new hemp-infused products and a breakthrough magnetic mask. Additionally, as part of its strategic plan to boost revenues, it has aligned with China GuiZhou HanTai Wine, Inc. (http://cnw.fm/5krVp) to begin baijiu liquor sales. Baijiu is a grain-based Chinese alcoholic beverage.

For more information, visit the company’s website at www.ChineseInvestors.com

More from CannabisNewsWire

About CannabisNewsWire

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Expanding Best-in-Class Product Line

Lexaria has developed an oral digestion technology that may translate into lower dosages and shorter treatment regimens
Company is expanding its edible product offerings through a licensing agreement with a Canadian cannabis chocolate manufacturer
Lexaria continues to develop products for demonstration, testing and sales

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has developed DehydraTECH™, an oral digestion technology believed to improve the absorption rates of nicotine, non-steroid anti-inflammatory drugs (NSAIDs), vitamins and cannabinoids by as much as five to ten times the normal rate. The time of onset is also reduced, and effects are felt within 15 to 20 minutes versus the normal 60 to 120 minutes. This proprietary technology also eliminates the undesired taste of cannabinoid edibles. By changing the way active pharmaceutical ingredients (APIs) enter the body, the user can benefit from lower dosages and quicker effects. The bioavailability of the APIs is improved, while side effects are tempered. As a result, this technology promotes far healthier ingestion methods than smoking or vaping.

Recently, the company announced its entry into a licensing agreement with Cannfections Group Inc. This agreement offers Lexaria the ability to provide commercial clients with high quality chocolate edibles. Cannfections is an infused chocolate and gummies contract manufacturer that was recently established by one of Canada’s oldest and most recognized chocolatiers. The owners of Cannfections have 85 years of experience in the chocolate-making industry that will lend to Lexaria’s long-term strategy of partnering with the world’s best to deliver best-in-class products.

Lexaria has developed various products for demonstration, testing and sales, showing wide applicability. These non-psychoactive cannabinoid products have a high-absorption hemp oil formula, are an excellent source of omegas and essential fatty acids and are engineered for physiological performance and recovery. APIs within Lexaria’s products have been shown to reduce anxiety and stress while promoting focus, offsetting pain and inflammation and supporting circulation.

The company’s sports nutrition focus resulted in its Protein Energy Bars, which are a high source of energy, fiber and protein. ViPova™ branded premium teas deliver cannabidiol in several flavors and are high in anti-oxidants. TurboCBD™ hemp oil capsules are formulated with American ginseng and ginkgo biloba for enhanced focus and memory, and reduced stress and fatigue. Mouth-melt tablets are zero-sugar, rapidly dissolve, and combine the antioxidant properties of pterostilbene with hemp oil. Finally, Lexaria’s beverages are sparkling-clear with no hint of hemp oil flavors. With a continued focus on high quality and cutting edge technology, Lexaria is investigating and will continue to pursue additional technologies.

For more information, visit the company’s website at www.LexariaEnergy.com

More from CannabisNewsWire

About CannabisNewsWire

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Teewinot Life Sciences Corporation is Producing Cannabinoids without Touching the Plant

Producing cannabinoids through biosynthesis
CANNSYNTHESIS® platform has capacity to scale up
Revenues from out-licensing technology

For the half a billion or so who suffer from one type or another of diabetes, biosynthesis offers a lifeline. For it is through biosynthesis that much of the world’s insulin is produced. Insulin regulates the metamorphosis of fats and protein and, importantly, allows the cells in the muscles, fat and liver to absorb glucose from the blood. When the body does not produce enough insulin nor use the insulin it produces efficiently, blood sugar levels may rise dangerously. However, biosynthesis, a mid-twentieth century technology, is not employed solely in producing insulin but finds application in many other fields. For example, Teewinot Life Sciences Corporation uses biosynthesis to produce cannabinoids, a method of manufacture that is much less costly than growing cannabis plants and extracting the cannabinoids. With biosynthesis, Teewinot Life Sciences is able to produce cannabinoids without touching the cannabis plant.

Despite changing attitudes, cannabis remains a prohibited or controlled substance in many jurisdictions worldwide. In the U.S., for example, it is regulated pursuant to the Controlled Substances Act of 1970, under which authorities have classified marijuana as a Schedule I drug, alongside heroin and LSD. By so doing, all cannabinoids risk being tainted with illegality if they are extracted from the marijuana plant. However, most cannabinoids produced biosynthetically may escape the prohibitions of the CSA, since only THC is specifically mentioned in Schedule I.

Teewinot manufactures cannabinoids that have the same chemical structure as naturally-occurring phytocannabinoids by means of its patent-protected methods. These proprietary methods of manufacturing cannabinoids are less expensive than growing cannabis plants and extracting the cannabinoids. Moreover, the technology can be used to cost-effectively manufacture cannabinoid pro-drugs and cannabinoid analogs that do not naturally occur in the cannabis plant. A pro-drug is a substance that is metabolized by the body into a pharmacologically-active agent. Perhaps the best known pro-drug is paracetamol (acetaminophen), which is now thought to exert its analgesic (and probably anti-pyretic) effects by metamorphosizing into an anandamide, an endocannabinoid. In very general terms, this means that in the human body, paracetamol degrades to a cannabimimetic, or a substance that mimics a cannabinoid.

Developed by its labs in Vancouver, British Columbia, and Steinbach, Manitoba, this groundbreaking biosynthesis technology has long outgrown its micro environment. Teewinot Life Sciences has developed CannSynthesis™ to be employed for the large-scale manufacture of pharmaceutically pure cannabinoids. The technology has been licensed for the commercial production of the first analytical standard of CBCA (cannabichromenic acid) and for the manufacture of a patent-protected pro-drug of a cannabinoid. Teewinot’s cannabinoid pro-drugs are designed to be more bioavailable and stable in the human body, thereby increasing their efficacy.

Apart from THC and CBD, many of the 111 or so cannabinoids found in the cannabis plant are produced in minute quantities. Production by extraction is thus prohibitively costly, meaning that most cannabinoids have not been available for research and therapeutic applications. The CANNSYNTHESIS® platform has changed that paradigm, however, since it allows for the efficient production of cannabinoids in kilogram quantities. Teewinot’s CANNSYNTHESIS® has taken the production of cannabinoids from the lab to clinical settings, since the technology can deliver consistent and controlled dosages. Buoyed by its successes, the company continues to work with leading universities and pharmaceutical companies to provide novel patient therapies.

For more information, visit the company’s website at www.TLSCorp.com

More from CannabisNewsWire

About CannabisNewsWire

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Opportunity Amid Cannabis Banking Hurdles

CannabisNewsWire Editorial Coverage: Investors seeking opportunities in the cannabis market may want to turn their attention toward companies offering solutions for a situation that could otherwise slow the industry’s growth. A number of emerging firms are providing or pursuing payment options that can help cannabis companies sidestep the roadblock created by the lack of access to traditional banking services. Among the companies honing financing, payment processing and other business development services for the cannabis industry are Global Payout, Inc (OTC: GOHE) (GOHE Profile), MassRoots Retail (OTC: MSRT), iAnthus Capital Holdings, Inc. (CSE: IAN) (OTC: ITHUF), and Glance Technologies, Inc. (OTC: GLNNF) (GET: CNX). Meanwhile, recent action at Canopy Growth Corp. (CC: WEED) demonstrates that a change in bank industry policy could be on the horizon.

In Arizona, the state Department of Health Services reported that its dispensaries sold over 43 tons of medical marijuana through year-end 2017, an increase of 48 percent from 2016. Capitol Media Services estimates the quantity of medical marijuana sold in Arizona in 2017 represented approximately $275 million in retail sales for the year. Sales in the United States as a whole represent a multibillion dollar market that is only expected to grow as the legalization process continues to spread. In Canada alone, taking into account the planned July 2018 legalization of recreational cannabis, sales of the product are expected to reach C$6 billion by 2021.

Despite the massive sales figures, cannabis companies largely conduct business in cash. With marijuana classified as a Schedule 1 drug at the federal level in the United States, the cannabis industry is essentially unbankable there, creating an opportunity for companies that can help industry participants process the payments generated by cannabis sales.

The Struggle to Organize Necessary Elements of Infrastructure

For the time being, cannabis businesses continue to struggle with financing issues related to customer receipts and budget expenditures, especially in the United States. While U.S. banks have overwhelmingly refrained from doing business with cannabis companies due to the federal prohibition on sales of the product, in Canada some banks have begun to offer business accounts to cannabis companies. Even when Canada does begin legalization in mid-2018, however, there’s no guarantee its banks will be quick to finance cannabis companies. The year is expected to be a landmark period for cannabis-related businesses, yet there’s still a fair amount of uncertainty about how they will fare. Global Payout, Inc. (OTC: GOHE) is one company positioned to help alleviate that uncertainty through a number of payment processing services.

Payment Solutions for the “Unbankable”

Global Payout’s fintech payment solutions can be fully customized for virtually any domestic and international organization distributing money worldwide. Through its MoneyTrac Technology (“MTRAC”) subsidiary, Global Payout is focused on helping reduce the extensive security, accounting and overhead costs dispensaries face from having to deal exclusively in cash. The reliance on cash transactions by cannabis businesses leaves these companies vulnerable to theft and facing all the inconvenience associated with running a cash-only business. And the problem is only expected to grow more acute as the rapidly growing multibillion-dollar industry continues to expand, with cannabis now recreationally available in eight states.

Addressing this opportunity in the company’s letter to shareholders, Global Payout CEO James Hancock stated: “Recognizing the gap between adequate financial technology solutions and the rapidly expanding, multi-billion-dollar cannabis industry, a collective decision was made in March to spinout our majority owned subsidiary, MoneyTrac Technology to begin serving the underserved businesses of the cannabis industry. … These partnerships, combined with several other important developments throughout the year, have effectively positioned MoneyTrac to generate revenue and become a recognized leader of a variety of service and solution offerings within the cannabis industry.”

MTRAC plans to launch its regulatory compliant token offering in the first quarter of 2018 as part of an effective, decentralized system for processing payments (http://cnw.fm/eoPQ3). The M-Token from MTRAC will allow vulnerable businesses to migrate from a cash-only business model by offering the basic yet essential services denied to them by the traditional banking industry. In the process, the businesses can improve their security and boost their operational efficiency.

Vanessa Luna, CEO of MTRAC, stated, “MoneyTrac’s primary objective has been, and will continue to be, to serve the legitimate and profitable businesses of the cannabis industry by effectively addressing the financial technology and banking challenges they are faced with. … Our regulatory compliant Token Offering will revolutionize how these businesses operate and help MTRAC further its objectives for identifying various partnerships and cultivating the relationships necessary to pave the way for alternative banking solutions.”

Cannabis Compliance

To help it develop a strong foundation for the delivery of banking solutions to the legal cannabis industry, MTRAC recently signed a joint-venture agreement with Integrated Compliance Solutions, LLC (“ICS”), a leading provider of financial regulatory compliance services and solutions to the retail cannabis industry. The partnership bolsters MTRAC’s ability to provide compliant banking solutions with its strategic partners.

In the press release announcing the agreement, Luna emphasized the importance in maintaining compliance in the heavily regulated retail cannabis industry.

“The ICS team carries several years of valuable experience with them in the field of regulatory compliance solutions and financial technology services for banking, and their integration into the banking solutions (that) we are dedicated to delivering to the cannabis industry is not only significant, but essential to our commitment of providing retail cannabis businesses with the most compliant and regulated banking solution available,” she stated (http://cnw.fm/xiq7H).

Exploring Expanded Marketing Opportunities

Global Payout also recently signed a Sales Partnership Agreement with Eyeconic.tv in a move to explore the potential of creating new revenue streams (http://cnw.fm/vnXs7) while boosting the impact of both parties.

The companies plan to leverage the network of dispensaries and industry-specific brands and products established through MTRAC’s PotSaver publication in conjunction with Eyeconic.tv’s digital media platform. Eyeconic.tv is an innovative producer and distributor of interactive digital mediums focused mainly on digital menus, advertising and kiosks to customers on their business premises. PotSaver is a revenue-producing community periodical and online advertising platform that provides listings for discounted cannabis-related products to local dispensaries and shops.

“Establishing this sales partnership with Eyeconic.tv is an incredibly effective way to deliver more value to the solutions and services we are providing to cannabis-related businesses. The Eyeconic.tv team are true pioneers in the digital marketing and advertisement space and have established themselves as the premier provider of these services throughout the cannabis industry. I am pleased they recognize the value we can bring to their brand through the network of dispensaries we have created through our PotSaver publication, as well as through the invaluable expertise our team offers in developing and implementing successful sales and marketing strategies. I am extremely confident that this will be a partnership that is mutually beneficial to the objectives of each of our companies,” Luna said.

Additional Cannabis Payment Solution-Related Opportunities

In a sign that Canadian banks are beginning to change their position about financing cannabis firms, Canopy Growth Corp (CC: WEED), a diversified Canadian cannabis company that offers curated cannabis in dried, oil and capsule form, has recently announced a $175 million bought stock offering led by two major Canadian investment banks — Bank of Montreal, through its BMO Capital Markets division, and GMP Securities. Canopy Growth operates on four continents where it sells cannabis products, conducts R&D, and provides cannabis-related education for healthcare practitioners.

While Canadian banks may be beginning to change their stance on financing cannabis firms, it should be noted there are no signs of such a thaw to the south where banks continue to avoid doing business with cannabis firms because of federal regulations. Canopy Growth’s extensive operations outside of Canada mean that the firm can still benefit from payment solutions that enable it to reduce the amount of cash transactions it conducts.

MassRoots (OTC: MSRT) offers one of the most popular technology platforms for the regulated cannabis industry. The company’s mobile apps, with more than a million users, enable consumers to draw on community-sourced reviews to make educated cannabis purchasing decisions. The company offers a compliance and point-of-sale system called MassRoots Retail, which helps cannabis businesses conduct retail operations more efficiently and manage compliance reporting as required by state regulators. MassRoots has recently formed a blockchain subsidiary focused on developing solutions for the cannabis industry based on the blockchain. The company believes that making use of the transparent digital ledger that constitutes the blockchain can help the cannabis industry operate with greater efficiency, accountability and transparency.

iAnthus Capital Holdings (CSE: IAN) (OTC: ITHUF) offers investors exposure to licensed cannabis cultivators, processors and dispensaries located across the United States. The company offers capital as well as hands-on operational and management expertise. With seven investments in six states covering an addressable market of approximately 50 million people, the company’s dispensaries stand to benefit from access to innovative payment processing and financial solutions that enable them to more efficiently handle transactions.

Glance Technologies, Inc. (OTC: GLNNF) (GET: CNX) owns Glance Pay, a mobile payment system transforming the way smartphone users interact with merchants and buy products. The company’s partially owned subsidiary, Cannapay Financial, is the vehicle for Glance Technologies’ entry into the cannabis industry through licensing agreements that leverage the Glance Pay App and the Glance Merchant App’s data analytics. Cannapay Financial has two apps in development — Cannapay, a mobile-to-mobile payment system for the marijuana industry, and SuperDope Delivery, a mobile ordering and delivery app for cannabis consumers.

The tremendous growth being experienced by the cannabis industry, coupled with the difficulty cannabis businesses are experiencing in accessing banking services, especially in the United States, have created significant opportunities for firms that can offer these businesses effective methods of processing transactions. Each of the companies listed above is positioned to benefit from this evolving trend, making them worthy of further investigation by investors looking to capitalize on the expansion of the cannabis industry and the corresponding development of payment solutions to facilitate that expansion.

For more information on Global Payout, visit Global Payout, Inc. (GOHE)

About CannabisNewsWire

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

Earth Science Tech, Inc. (ETST) Eyes Uplisting to OTCQB, Retains Counsel for Planned Regulation A+ Tier 2 Financing

Goal is to raise $4 million to help company finance its planned projects
Expansion into Canada eyed, attorney retained to help seek Canadian licenses to import ETST’s CBD-rich hemp oil into country
ETST would also use funding for MSN-2, its home kit for the detection of sexually transmitted diseases

Earth Science Tech, Inc. (OTC: ETST) is working toward an uplisting to the OTCQB Venture Market in early 2018. It has also retained counsel for a planned Regulation A+ Tier 2 round of financing, which the company hopes will raise an aggregate of $4 million (http://cnw.fm/W8I2d). The funds would be used to finance its planned projects in the new year and for general working capital (http://cnw.fm/Pi0hl), with share cancellation by company founders counteracting dilution.

ETST is also eyeing expansion into Canada in 2018, and it has appointed an attorney who will serve as consultant for ETST’s activities in that country, Avi Levi, Esq. (http://cnw.fm/aW8ww). He will help the company apply for licenses to import its CBD-rich hemp oil into Canada. It will then be exported to various countries as raw hemp oil or in individual ready-to-consume bottles, the company said.

Dr. Michel Aube, CEO and chief scientific officer of the company, said, “With the funds being raised through the Regulation A+ offering, we will be in a position to begin finalizing all of our projects while we pursue grants from the Canadian government to cover our MSN-2 medical device, CBD patent pending formulas and CBD based generic pharmaceutical drugs.”

The MSN-2 device is prepared for third-party evaluation ahead of manufacture and commercialization. The MSN-2 device is a home kit designed for the detection of sexually transmitted diseases.

ETST is a biotechnology company operating in the fields of hemp cannabinoid pharmaceutical, nutraceutical, and medical device R&D. Its hemp CBD is made using the liquid extraction process. As a result, its CBD oil is 100 percent natural and organic, as noted by the company.

ETST has three wholly owned subsidiaries. First, Earth Science Pharma, Inc. specializes in the development of medical devices for the treatment of sexually transmitted diseases. Second, Cannabis Therapeutics, Inc. works to explore the medicinal powers of CBD. Cannabis Therapeutics holds a provisional application patent for a CBD product which develops treatments for ovarian and breast cancers. Third, KannaBidioid, Inc. focuses on the recreational cannabis space.

For more information, visit the company’s website at www.EarthScienceTech.com

More from CannabisNewsWire

About CannabisNewsWire

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

EVIO, Inc. (EVIO) is Exceeding Expectations

Investor interest nearly doubles size of placement
Company’s 2017 revenues soared 438 percent year-over-year
On pace to double number of testing facilities this year

The regulatory uncertainties surrounding cannabis will have little impact on the long-term growth of the industry. There’s overwhelming scientific evidence validating the medical efficacy of certain cannabinoids and, like all medications, cannabinoids require quality control assurances for potency and purity. Also, much like prohibition, it’s realistic to expect parochial federal regulators to ultimately succumb to the will of the majority and relax any uncertainties around recreational cannabis use. Again, the end product must be tested and screened for potency and any potentially harmful byproducts.

EVIO, Inc. (OTCQB: EVIO) is the established national leader in such testing and verification, providing accredited cannabis testing, as well as high-quality analytical and consulting services for agricultural and biomedical industries in the United States. Operating coast-to-coast, the company’s EVIO Labs division provides state-mandated ancillary services to ensure both safety and quality of the nation’s cannabis supply. The company provides state-of the-art analytical testing and advisory services, and it performs extensive product research in its accredited laboratory testing facilities.

In a recent vote of confidence for EVIO, as well as in the long-term viability and opportunities in the cannabis industry, EVIO just closed a $5,973,000 private placement. The initial target of $3 million was nearly doubled due to investor interest in EVIO’s uniquely scalable business model and scientific expertise in the cannabis testing space (http://cnw.fm/GaCw2).

Market savants fully understand that fresh capital seldom flows to dead-end deals, and doubling the raise is a significant signal of potential success. The best-efforts offering was completed on January 30 through lead agent and bookrunner Dominick Capital Corporation of Toronto, Canada.

As further evidence of EVIO’s growth curve, the company reported a 438 percent revenue increase on a year-over-year basis in its fiscal year ended September 30, 2017 (http://cnw.fm/ZtN6O). The vast majority of this growth came from increased testing revenue, which was up 782 percent, while consulting services increased by 27 percent.

EVIO has grown from one laboratory in Oregon to nine fully operational laboratories in California, Colorado, Florida, Massachusetts and Oregon, and it intends to open 18 laboratory facilities at other locations around the United States by the end of 2018.

For more information, visit the company’s website at www.EVIOLabs.com

More from CannabisNewsWire

About CannabisNewsWire

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Recent Report on PotNetwork Holding Inc. (POTN) Share Price Target Highlights Encouraging Data

Heightened share price target for PotNetwork Holding Inc. set at $1.25
Previous market estimates, exceeded by over 70 percent, show positive month-to-month sales for PotNetwork Holdings Inc.
SeeThruEquity report highlights the greatly lowered legal and physiological risk from hemp-derived CBD

A recent comprehensive report by SeeThruEquity highlighting PotNetwork Holding Inc. (OTC: POTN) and its subsidiary, Diamond CBD, projected a heightened share price target set at $1.25. The increase was attributed to the company’s strong monthly sales data and 3Q17 filings (http://cnw.fm/A2krk). Per the report, these indicated “continued profitability as the company invests in growth.”

In a prior news release, Dr. Richard Goulding, CEO of PotNetwork Holding Inc., stated, “It is very rewarding to experience this type of growth and success, and all the more pleasing to see an acknowledgement of our collective efforts in the marketplace.” This statement followed news that the company’s previously announced estimates of $8.3 million were exceeded by over 70 percent, reaching $14.5 million due to rapid month-to-month growth in sales (http://cnw.fm/Rt1p8).

SeeThruEquity’s report highlighted that hemp derived from CBD can provide a legal alternative to marijuana-based CBD, which is banned by federal law. This allows consumers to make use of CBD products without the risk of experiencing a ‘high’ or infringing on government law. The projected market for hemp-derived CBD is expected to grow at a CAGR of roughly 53 percent through 2020, positioning it among the fastest-growing segments within the multi-billion dollar legal cannabis and hemp market.

Cannabidiol (CBD) and tetrahydrocannabinol (THC) are the most researched derivatives of cannabis, a psychoactive drug also known as marijuana (http://cnw.fm/u83jV). The traditional ‘high’ associated with this drug is largely thanks to the presence of THC, and, while CBD is a structural isomer of THC (meaning that it has the same chemical composition), the atomic structure is arranged differently, offering many of the same health benefits without the psychoactive effects of THC. Based on numerous studies, CBD has demonstrated the capacity to produce a number of effects on the endocannabinoid system (ECS), including boosting immune system function, reducing sensations of pain, playing a role in inflammatory response and altering appetite, mood, memory and energy levels.

With the advancement of technology and ongoing research of the medicinal qualities of CBD, it is possible that these products could, potentially, serve as substitutes for harmful medications that are currently on the market. The natural healing properties are being assessed on a global level, and several journals have already noted the economic impact of CBD in general. Matt Karnes of Greenwave Advisors, in an interview with Forbes, stated, “In terms of the CBD market size, I estimate an almost $3 billion market by 2021. Right now, there are 15 states that allow CBD only — this is in addition to the 28 states plus DC that have legalized medical marijuana.”

Numerous studies on the positive effects of cannabinoids and THC have paved the way for legalization of marijuana for medicinal purposes in Canada and the U.S. A focus report by Mackie Research Capital Corp. (http://cnw.fm/Dgh2g) notes that (based on internal models) the Canadian marijuana market is expected to increase in size quickly, with the forecast peak in market size to exceed C$2.5 billion by 2020. With the United States presenting various states in which medicinal marijuana is legal, the market size for these states (most notably Colorado, Arizona, Oregon and Michigan) is projected to record a significant increase in growth from 2015 to 2020. For the above-mentioned states, the Colorado market is expected to reach more than $1.5 billion, Arizona is expected to exceed $453 million, Oregon could increase to $330 million and Michigan is expected to rise to $556 million, all by 2020.

PotNetwork Holding Inc. is a publicly traded company that acts as a holding company for a number of subsidiaries, namely First Capital Venture Co., PotNetwork.com, and Diamond CBD, Inc. The latter focuses on research, development and multinational marketing of hemp extracts containing a wide variety of cannabinoids and natural hemp derivatives. Diamond CBD’s team of hemp industry pioneers, chemists, doctors, scientists and natural product experts aims to produce high-grade CBD oil, providing a variety of CBD oils, tinctures, edibles and vape liquids.

In a previous news release (http://cnw.fm/6q5VV), Goulding added, “[W]e are proud, and think our shareholders should be too, that on December 13, 2017 PotNetwork Holding was named by Huffington Post, a prominent major national news source, as “One of Five Notable CBD Revolution Industry Leaders’, an accolade that pays tribute to the company’s achievements and future prospects.”

Goulding further noted, “2017 has been a phenomenally successful year for us! Our unprecedented sales growth pays tribute to the hard work of our staff and our resellers, and the exceptional quality of our CBD product line which expanded greatly over 2017.” He also emphasized that the company is poised for growth during 2018 and it embarks on new and unique marketing initiatives and embraces new opportunities.

Without question, the recent report by SeeThruEquity highlighting PotNetwork Holding Inc. and Diamond CBD projects not only an increased share price target, but also a positive expansion of the company within this multi-billion dollar arena. With an ever-increasing demand for safer products of this nature that abide by all governing regulations, PotNetwork Holding Inc., also with its subsidiaries, has its foot in the door of tomorrow’s market.

For more information, visit the company’s website at www.PotNetworkHolding.com

Pursuant to the applicable federal law, the sale or distribution of CBD with less than 0.03% of tetrahydrocannabinol by retailers may be permissible in all states. However, the local, state and federal laws regarding these issues tend to remain in flux and should be accordingly reviewed by local counsel and, as such, legal advice is not intended, but specifically disclaimed.

More from CannabisNewsWire

About CannabisNewsWire

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net